Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$47.5M |
| 2 |
Johnson & Johnson
JNJ
|
+$34.9M |
| 3 |
Phillips 66
PSX
|
+$34.7M |
| 4 |
Chevron
CVX
|
+$31.9M |
| 5 |
Johnson Controls International
JCI
|
+$31.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$51.8M |
| 2 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$49.5M |
| 3 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
+$48.2M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$37.7M |
| 5 |
STOR
STORE Capital Corporation
STOR
|
+$23.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.69% |
| 2 | Industrials | 11.81% |
| 3 | Healthcare | 11.19% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
PUT
American International
AIG
$40.5B
| $1.07M | 0.02% |
+21,300
| New | +$1.24M |
|
1152
CALL
LyondellBasell Industries
LYB
$21.1B
| $1.07M | 0.02% |
11,400
+1,800
| +19% | +$167K |
|
1153
Xenon Pharmaceuticals
XENE
$5.86B
| $1.07M | 0.02% |
+29,908
| New | +$1.1M |
|
1154
HNI Corp
HNI
$3.54B
| $1.07M | 0.02% |
38,400
+2,334
| +6% | +$69.3K |
|
1155
CALL
Alcoa
AA
$13B
| $1.07M | 0.02% |
+25,100
| New | +$1.21M |
|
1156
CALL
Linde
LIN
$226B
| $1.07M | 0.02% |
+3,000
| New | +$1M |
|
1157
Universal Corp
UVV
$1.14B
| $1.07M | 0.02% |
20,158
+5,042
| +33% | +$265K |
|
1158
Red Rock Resorts
RRR
$3.59B
| $1.06M | 0.02% |
+23,850
| New | +$1.05M |
|
1159
PUT
3M
MMM
$92.3B
| $1.06M | 0.02% |
12,080
+4,784
| +66% | +$451K |
|
1160
Melco Resorts & Entertainment
MLCO
$2.08B
| $1.06M | 0.02% |
+83,250
| New | +$1.07M |
|
|
FSR
1161
DELISTED
Fisker Inc.
FSR
| $1.06M | 0.02% |
+172,291
| New | +$1.19M |
|
|
FFWM
1162
DELISTED
First Foundation Inc
FFWM
| $1.06M | 0.02% |
141,859
-1,020
| -0.7% | -$13.6K |
|
1163
GoodRx Holdings
GDRX
$1.17B
| $1.06M | 0.02% |
169,187
-120,879
| -42% | -$674K |
|
1164
Intel
INTC
$461B
| $1.05M | 0.02% |
32,200
-200,475
| -86% | -$5.68M |
|
1165
CALL
Cigna
CI
$74.1B
| $1.05M | 0.02% |
4,100
-2,300
| -36% | -$670K |
|
1166
PUT
MGM Resorts International
MGM
$11B
| $1.05M | 0.02% |
+23,600
| New | +$981K |
|
|
HES
1167
PUT
DELISTED
Hess
HES
| $1.05M | 0.02% |
7,900
-7,000
| -47% | -$974K |
|
1168
CALL
Group 1 Automotive
GPI
$3.09B
| $1.04M | 0.02% |
+4,600
| New | +$976K |
|
1169
PUT
Apollo Global Management
APO
$78.4B
| $1.04M | 0.02% |
+16,500
| New | +$1.1M |
|
1170
Quanterix
QTRX
$132M
| $1.04M | 0.02% |
92,408
+12,795
| +16% | +$163K |
|
1171
Immunovant
IMVT
$8.95B
| $1.04M | 0.02% |
+67,019
| New | +$1.16M |
|
1172
CALL
J.M. Smucker
SJM
$13.5B
| $1.04M | 0.02% |
+6,600
| New | +$1M |
|
1173
CALL
PG&E
PCG
$39.9B
| $1.04M | 0.02% |
64,100
+28,700
| +81% | +$453K |
|
1174
Corcept Therapeutics
CORT
$13.3B
| $1.04M | 0.02% |
+47,879
| New | +$1.05M |
|
1175
Patria Investments
PAX
$1.85B
| $1.04M | 0.02% |
70,043
+29,790
| +74% | +$454K |
|
Similar funds
Paul Tudor Jones's Q1 2023 Portfolio in Review
As of Q1 2023, Paul Tudor Jones held 3,136 positions worth $6.46B, up 28% from $5.06B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Paul Tudor Jones deployed $1.28B of net new capital in Q1 2023, opening 836 new positions and adding to 737 existing holdings. Its largest new stake was Johnson & Johnson: 216,183 shares worth $33.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $37.7M trimmed.
- Paul Tudor Jones's largest Q1 2023 buy was Johnson & Johnson: 216,183 shares worth $33.5M.
- Paul Tudor Jones added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $47.5M increase.
- Paul Tudor Jones's biggest Q1 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $37.7M.
- Paul Tudor Jones fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $51.8M.
- Paul Tudor Jones's ten largest holdings make up 6.8% of its $6.46B portfolio in Q1 2023.
- Paul Tudor Jones opened 836 new positions and closed 800 in Q1 2023.
- Paul Tudor Jones's portfolio value rose 28% quarter-over-quarter to $6.46B.
Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.